Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure-Reference-Cited by-同舟云学术

Optimized Catheter System Demonstrates Utility for Endomyocardial Delivery of Cardiopoietic Stem Cells in Target Patients With Heart Failure

Published:2023-10-23 Issue:5 Volume:50 Page:
ISSN:1526-6702
Container-title:Texas Heart Institute Journal
language:en
Short-container-title:

Author:

Bartunek Jozef¹,Terzic Andre²

Affiliation:

1. 1Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium

2. 2Marriott Heart Disease Research Program, Center for Regenerative Medicine and Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota

Publisher

Texas Heart Institute Journal

Subject

Cardiology and Cardiovascular Medicine

Link

https://meridian.allenpress.com/thij/article-pdf/doi/10.14503/THIJ-23-8247/3280079/i1526-6702-50-5-e238247.pdf

Reference11 articles.

1. Delivery of biologics in cardiovascular regenerative medicine;Bartunek;Clin Pharmacol Ther,2009

2. Optimized delivery system achieves enhanced endomyocardial stem cell retention;Behfar;Circ Cardiovasc Interv,2013

3. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design;Bartunek;Eur J Heart Fail,2016

4. Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial;Bartunek;Eur Heart J,2017

5. Clinical experience with regenerative therapy in heart failure: advancing care with cardiopoietic stem cell interventions;Bartunek;Circ Res,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardisation is the key to the sustained, rapid and healthy development of stem cell‐based therapy;Clinical and Translational Medicine;2024-04